It will mostly be the major domestic players and MNCs that will thrive in China’s infant formula market in the upcoming years, claim experts, citing a raft of reasons such as a more stringent regulatory environment, negative population growth, and an...
China infant formula firm Feihe said the popularity of its brands Astrobaby and Organic Zhenzhi have helped increase revenue for its infant milk portfolio by 41 per cent in FY2020, but its US dominated supplements business had plunged by 46 per cent.
